Patent & Trade Mark
Attorneys
We are
Experts in Navigating IP in the Asia Pacific Region
Working with clients in
Thanks to many years of global experience, FB Rice has a network of trusted advisors in all key jurisdictions. We turn to those advisors when assisting our clients to promote their interests.

For specific information on our Asia Pacific capability, click here.
One door to South East Asia
For a seamless service for filing and prosecuting patent and trade mark applications in South East Asia, click here.
Steve Gledhill

Partner

Steve Gledhill
"At FB Rice we have a number of high calibre European Qualified Attorneys who are also registered Australian and New Zealand Patent Attorneys. These attorneys have many years’ experience successfully securing strong IP rights and translating Australian and New Zealand patenting issues to clients filing from or into Europe and the United Kingdom."
"At FB Rice we have a number of high calibre European Qualified Attorneys who are also registered Australian and New Zealand Patent Attorneys. These attorneys have many years’ experience successfully securing strong IP rights and translating Australian and New Zealand patenting issues to clients filing from or into Europe and the United Kingdom."
Australia: Change to patent examiners manual creates uncertainty
It is a long-standing principle of Australian patent law that determining whether or not a patent application is directed towards patentable subject matter should be done separately to determining issues of novelty and inventive step. However, amendments to the Australian Patent Examiners Manual late last year introduced a new practice, encouraging consideration of prior art when assessing subject matter eligibility, which in Australia includes the requirement that the invention be a manner of manufacture.
It is a long-standing principle of Australian patent law that determining whether or not a patent application is directed towards patentable subject matter should be done separately to determining issues of novelty and inventive step. However, amendments to the Australian Patent Examiners Manual late last year introduced a new practice, encouraging consideration of prior art when assessing subject matter eligibility, which in Australia includes the requirement that the invention be a manner of manufacture.
03 September 2018
New Zealand’s second-tier patent system fails to advance
The prospect of a second-tier patent system in New Zealand has failed to advance past first base, with the New Zealand Government halting the progress of the “Advancement Patent” following its first reading.
The prospect of a second-tier patent system in New Zealand has failed to advance past first base, with the New Zealand Government halting the progress of the “Advancement Patent” following its first reading.
Cameron Smith

Senior Associate

Cameron Smith

Cameron is a registered Australian and New Zealand Patent Attorney with extensive experience in managing International patent portfolios in the Biotechnology space. Regular counsel is provided to clients in relation to strategic planning, due diligence and patentability advice with clients ranging from publicly listed biotechnology companies to smaller ‘start-up’ companies and university commercialisation teams. Counsel is primarily sought after in relation to diagnostics and biological therapeutics such as antibodies and stem cells.

Cameron is a registered Australian and New Zealand Patent Attorney with extensive experience in managing International patent portfolios in the Biotechnology space. Regular counsel is provided to clients in relation to strategic planning, due diligence and patentability advice with clients ranging from publicly listed biotechnology companies to smaller ‘start-up’ companies and university commercialisation teams. Counsel is primarily sought after in relation to diagnostics and biological therapeutics such as antibodies and stem cells.

22 May 2018
FB Rice IP Stars | Managing Intellectual Property
We are delighted with the news that so many of our Partners have been singled out as IP Stars by leading intellectual property magazine Managing Intellectual Property (MIP).
We are delighted with the news that so many of our Partners have been singled out as IP Stars by leading intellectual property magazine Managing Intellectual Property (MIP).
Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.
The Australian Patent Office (APO) has determined that claims directed to a composition comprising double-stranded RNA (so-called “interfering RNA” or “iRNA”) is a manner of manufacture (patent eligible subject matter) in accordance with Section 18(1)(a) of the Patents Act.